Your browser doesn't support javascript.
loading
Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.
Kleineidam, Luca; Wolfsgruber, Steffen; Weyrauch, Anne-Sophie; Zulka, Linn E; Forstmeier, Simon; Roeske, Sandra; van den Bussche, Hendrik; Kaduszkiewicz, Hanna; Wiese, Birgitt; Weyerer, Siegfried; Werle, Jochen; Fuchs, Angela; Pentzek, Michael; Brettschneider, Christian; König, Hans-Helmut; Weeg, Dagmar; Bickel, Horst; Luppa, Melanie; Rodriguez, Francisca S; Freiesleben, Silka Dawn; Erdogan, Selin; Unterfeld, Chantal; Peters, Oliver; Spruth, Eike J; Altenstein, Slawek; Lohse, Andrea; Priller, Josef; Fliessbach, Klaus; Kobeleva, Xenia; Schneider, Anja; Bartels, Claudia; Schott, Björn H; Wiltfang, Jens; Maier, Franziska; Glanz, Wenzel; Incesoy, Enise I; Butryn, Michaela; Düzel, Emrah; Buerger, Katharina; Janowitz, Daniel; Ewers, Michael; Rauchmann, Boris-Stephan; Perneczky, Robert; Kilimann, Ingo; Görß, Doreen; Teipel, Stefan; Laske, Christoph; Munk, Matthias H J; Spottke, Annika; Roy, Nina.
Afiliação
  • Kleineidam L; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Wolfsgruber S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Weyrauch AS; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Zulka LE; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Forstmeier S; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Roeske S; Department of Psychology and Centre for Ageing and Health (AgeCap), University of Gothenburg, Gothenburg, Sweden.
  • van den Bussche H; Developmental Psychology and Clinical Psychology of the Lifespan, University of Siegen, Siegen, Germany.
  • Kaduszkiewicz H; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Wiese B; Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Weyerer S; Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Werle J; Medical Faculty, Institute of General Practice, University of Kiel, Kiel, Germany.
  • Fuchs A; Center for Information Management, Hannover Medical School, Hanover, Germany.
  • Pentzek M; Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Heidelberg, Germany.
  • Brettschneider C; Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Heidelberg, Germany.
  • König HH; Medical Faculty, Centre for Health and Society (CHS), Institute of General Practice (ifam), Heinrich Heine University, Düsseldorf, Germany.
  • Weeg D; Medical Faculty, Centre for Health and Society (CHS), Institute of General Practice (ifam), Heinrich Heine University, Düsseldorf, Germany.
  • Bickel H; Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Luppa M; Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rodriguez FS; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
  • Freiesleben SD; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
  • Erdogan S; Medical Faculty, Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.
  • Unterfeld C; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Peters O; Medical Faculty, Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.
  • Spruth EJ; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Altenstein S; Department of Psychiatry, Campus Berlin-Buch, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
  • Lohse A; Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), Berlin, Germany.
  • Priller J; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Fliessbach K; Department of Psychiatry, Campus Berlin-Buch, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
  • Kobeleva X; Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), Berlin, Germany.
  • Schneider A; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Bartels C; Department of Psychiatry, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
  • Schott BH; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Wiltfang J; Department of Psychiatry, Campus Berlin-Buch, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
  • Maier F; Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), Berlin, Germany.
  • Glanz W; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Incesoy EI; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Butryn M; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Düzel E; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Buerger K; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Janowitz D; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
  • Ewers M; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Rauchmann BS; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Perneczky R; University of Edinburgh and UK DRI, Edinburgh, United Kingdom.
  • Kilimann I; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Görß D; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Teipel S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Laske C; Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
  • Munk MHJ; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Spottke A; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
  • Roy N; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
Front Psychol ; 13: 957308, 2022.
Article em En | MEDLINE | ID: mdl-36571008
Introduction: Several lifestyle factors promote protection against Alzheimer's disease (AD) throughout a person's lifespan. Although such protective effects have been described for occupational cognitive requirements (OCR) in midlife, it is currently unknown whether they are conveyed by brain maintenance (BM), brain reserve (BR), or cognitive reserve (CR) or a combination of them. Methods: We systematically derived hypotheses for these resilience concepts and tested them in the population-based AgeCoDe cohort and memory clinic-based AD high-risk DELCODE study. The OCR score (OCRS) was measured using job activities based on the O*NET occupational classification system. Four sets of analyses were conducted: (1) the interaction of OCR and APOE-ε4 with regard to cognitive decline (N = 2,369, AgeCoDe), (2) association with differentially shaped retrospective trajectories before the onset of dementia of the Alzheimer's type (DAT; N = 474, AgeCoDe), (3) cross-sectional interaction of the OCR and cerebrospinal fluid (CSF) AD biomarkers and brain structural measures regarding memory function (N = 873, DELCODE), and (4) cross-sectional and longitudinal association of OCR with CSF AD biomarkers and brain structural measures (N = 873, DELCODE). Results: Regarding (1), higher OCRS was associated with a reduced association of APOE-ε4 with cognitive decline (mean follow-up = 6.03 years), consistent with CR and BR. Regarding (2), high OCRS was associated with a later onset but subsequently stronger cognitive decline in individuals converting to DAT, consistent with CR. Regarding (3), higher OCRS was associated with a weaker association of the CSF Aß42/40 ratio and hippocampal volume with memory function, consistent with CR. Regarding (4), OCR was not associated with the levels or changes in CSF AD biomarkers (mean follow-up = 2.61 years). We found a cross-sectional, age-independent association of OCRS with some MRI markers, but no association with 1-year-change. OCR was not associated with the intracranial volume. These results are not completely consistent with those of BR or BM. Discussion: Our results support the link between OCR and CR. Promoting and seeking complex and stimulating work conditions in midlife could therefore contribute to increased resistance to pathologies in old age and might complement prevention measures aimed at reducing pathology.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Psychol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Psychol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha